These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7404577)

  • 1. Acidic glycosaminoglycans in cultured skin fibroblasts of a patient with epidermolysis bullosa acquisita.
    Igarashi M; Takahashi M; Seiji M
    Tohoku J Exp Med; 1980 May; 131(1):79-88. PubMed ID: 7404577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic glycosaminoglycans in cultured skin fibroblasts of a patient with epidermolysis bullosa dystrophica dominans.
    Igarashi M; Seiji M
    Tohoku J Exp Med; 1980 Feb; 130(2):207-8. PubMed ID: 7385228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glycosaminoglycan accumulation as a genetic characteristic in cell cultures of one variety of dominant dystrophic epidermolysis bullosa.
    Bauer EA; Fiehler WK; Esterly NB
    J Clin Invest; 1979 Jul; 64(1):32-9. PubMed ID: 447858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acid glycosaminoglycans by the skin, urine, plasma and skin fibroblasts in a patient with dominant dystrophic epidermolysis bullosa (Cockayne-Touraine type)].
    Oyama K; Tajima S; Nishikawa T; Yamasaki Y; Araki Y; Sakuraoka K
    Nihon Hifuka Gakkai Zasshi; 1987 Sep; 97(10):1095-100. PubMed ID: 3441023
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteoglycans in cultures of skin fibroblasts in recessive dystrophic epidermolysis bullosa.
    Gregory JD; Moy JA; Damle SP
    J Dermatol Sci; 1993 Feb; 5(1):40-9. PubMed ID: 8485112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.
    Woodley DT; Gammon WR
    Cutis; 1983 Dec; 32(6):521-7. PubMed ID: 6357643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen.
    Woodley DT; O'Keefe EJ; McDonald JA; Reese MJ; Briggaman RA; Gammon WR
    J Clin Invest; 1987 Jun; 79(6):1826-30. PubMed ID: 3584471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.
    Stricklin GP; Welgus HG; Bauer EA
    J Clin Invest; 1982 Jun; 69(6):1373-83. PubMed ID: 6282934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium.
    Woodley DT; Briggaman RA; Gammon WR; O'Keefe EJ
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1267-72. PubMed ID: 2411267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment].
    Hintner H; Schuler G; Fritsch P
    Hautarzt; 1982 Jun; 33(6):310-4. PubMed ID: 6179897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPIDERMOLYSIS BULLOSA ACQUISITA: A DISEASE OF DERMAL CONNECTIVE TISSUE.
    PASS F; DOBSON RL
    Arch Dermatol; 1965 Mar; 91():219-23. PubMed ID: 14246157
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycosaminoglycans production by cultured skin fibroblasts from the Pasini and Cockayne-Touraine forms of dominant dystrophic epidermolysis bullosa.
    Priestley GC
    J Invest Dermatol; 1991 Feb; 96(2):168-71. PubMed ID: 1991977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of glycosaminoglycans by human skin fibroblasts cultured on collagen gels.
    Gallagher JT; Gasiunas N; Schor SL
    Biochem J; 1980 Aug; 190(2):243-54. PubMed ID: 7470051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis.
    Tatnall FM; Whitehead PC; Black MM; Wojnarowska F; Leigh IM
    Br J Dermatol; 1989 Apr; 120(4):533-9. PubMed ID: 2730844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
    Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
    N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
    Gardner KM; Crawford RI
    J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-beta-glucosaminidase activity in serum of patients with epidermolysis bullosa.
    Igarashi M
    Tohoku J Exp Med; 1983 Dec; 141(4):491-2. PubMed ID: 6367145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus.
    Boh E; Roberts LJ; Lieu TS; Gammon WR; Sontheimer RD
    J Am Acad Dermatol; 1990 Apr; 22(4):587-93. PubMed ID: 2319019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen synthesis and degradation by epidermolysis bullosa fibroblasts.
    Oakley CA; Priestley GC
    Acta Derm Venereol; 1985; 65(4):277-81. PubMed ID: 2413679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.